Wang, David http://orcid.org/0000-0001-5427-4961
Hung, Tak
Hung, Noelyn
Glue, Paul
Jackson, Chris
Duffull, Stephen
Article History
Received: 25 April 2023
Accepted: 31 July 2023
First Online: 10 August 2023
Declarations
:
: D.W. received the University of Otago Doctoral scholarship. T.H. is the owner of Zenith Technology Limited contracted to perform the Phase I trial reported by Athenex Limited. N.H. is the medical director of Zenith Technology Limited. C.J., S.D., P.G. have no conflicts of interests to disclose.